TNB Tech Minute: OpenAI Publishes New AI Policy Proposals
WSJ Tech News Briefing
00:00
Neurocrine buys Soleno for rare-disease drug
Danny Lewis explains Neurocrine's $2.9 billion acquisition to expand endocrinology and rare-disease offerings.
Play episode from 01:44
Transcript
